| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 453 | 2020 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 387 | 2022 |
| Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis FPS Santos, HM Kantarjian, N Jain, T Manshouri, DA Thomas, ... Blood, The Journal of the American Society of Hematology 115 (6), 1131-1136, 2010 | 287 | 2010 |
| Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib KP Patel, KJ Newberry, R Luthra, E Jabbour, S Pierce, J Cortes, R Singh, ... Blood, The Journal of the American Society of Hematology 126 (6), 790-797, 2015 | 194 | 2015 |
| Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia A Quintas-Cardama, FPS Santos, G Garcia-Manero Leukemia 25 (2), 226-235, 2011 | 185 | 2011 |
| Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia FPS Santos, D Jones, W Qiao, JE Cortes, F Ravandi, EE Estey, D Verma, ... Cancer 117 (10), 2145-2155, 2011 | 175 | 2011 |
| Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study I Esteves, C Bonfim, R Pasquini, V Funke, NF Pereira, V Rocha, Y Novis, ... Bone marrow transplantation 50 (5), 685-689, 2015 | 169 | 2015 |
| Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy F Ravandi, J Cortes, S Faderl, S O'Brien, G Garcia-Manero, S Verstovsek, ... Blood, The Journal of the American Society of Hematology 116 (26), 5818-5823, 2010 | 116 | 2010 |
| Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase … E Jabbour, J Cortes, FPS Santos, D Jones, S O'Brien, G Rondon, U Popat, ... Blood, The Journal of the American Society of Hematology 117 (13), 3641-3647, 2011 | 98 | 2011 |
| Decitabine in the treatment of myelodysplastic syndromes FPS Santos, H Kantarjian, G Garcia-Manero, JP Issa, F Ravandi Expert review of anticancer therapy 10 (1), 9-22, 2010 | 97 | 2010 |
| Evolution of therapies for chronic myelogenous leukemia FPS Santos, H Kantarjian, A Quintás-Cardama, J Cortes The Cancer Journal 17 (6), 465-476, 2011 | 94 | 2011 |
| JAK2 inhibitors: what's the true therapeutic potential? FPS Santos, S Verstovsek Blood reviews 25 (2), 53-63, 2011 | 94 | 2011 |
| Therapy with azanucleosides for myelodysplastic syndromes A Quintás-Cardama, FPS Santos, G Garcia-Manero Nature reviews Clinical oncology 7 (8), 433-444, 2010 | 89 | 2010 |
| Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution FPS Santos, S Faderl, G Garcia-Manero, C Koller, M Beran, S O'Brien, ... Leukemia 23 (12), 2275-2280, 2009 | 88 | 2009 |
| Allogeneic transplantation in first remission improves outcomes irrespective of FLT3-ITD allelic ratio in FLT3-ITD–positive acute myelogenous leukemia B Oran, J Cortes, A Beitinjaneh, HC Chen, M de Lima, K Patel, F Ravandi, ... Biology of Blood and Marrow Transplantation 22 (7), 1218-1226, 2016 | 77 | 2016 |
| Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease? FPS Santos, S O’Brien The Cancer Journal 18 (5), 396-403, 2012 | 70 | 2012 |
| Prognostic impact of RAS-pathway mutations in patients with myelofibrosis FPS Santos, B Getta, L Masarova, C Famulare, J Schulman, TS Datoguia, ... Leukemia 34 (3), 799-810, 2020 | 69 | 2020 |
| Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation FPS Santos, CS Tam, H Kantarjian, J Cortes, D Thomas, R Pollock, ... Leukemia & lymphoma 55 (1), 121-127, 2014 | 65 | 2014 |
| Bafetinib, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia. FP Santos, H Kantarjian, J Cortes, A Quintas-Cardama Current Opinion in Investigational Drugs (London, England: 2000) 11 (12 …, 2010 | 65 | 2010 |
| Citrus pulp as a dietary source of antioxidants for lactating Holstein cows fed highly polyunsaturated fatty acid diets GT Santos, LS Lima, ALB Schogor, JV Romero, FE De Marchi, PA Grande, ... Asian-Australasian journal of animal sciences 27 (8), 1104, 2014 | 64 | 2014 |
